604 related articles for article (PubMed ID: 16738691)
21. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
22. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
[TBL] [Abstract][Full Text] [Related]
23. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
[TBL] [Abstract][Full Text] [Related]
24. Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.
Wade J; Sterjovski J; Gray L; Roche M; Chiavaroli L; Ellett A; Jakobsen MR; Cowley D; Pereira Cda F; Saksena N; Wang B; Purcell DF; Karlsson I; Fenyö EM; Churchill M; Gorry PR
Virology; 2010 Jan; 396(2):246-55. PubMed ID: 19913863
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.
Nasreddine N; Borde C; Gozlan J; Bélec L; Maréchal V; Hocini H
J Immunol; 2011 May; 186(10):5687-95. PubMed ID: 21478402
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
[TBL] [Abstract][Full Text] [Related]
29. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
30. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo.
Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS
J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.
Binninger-Schinzel D; Müller D; Wolf T; Krause B; Meye B; Winskowsky G; Raupp S; Norley S; Brodt R; Werner A
J Med Virol; 2008 Feb; 80(2):192-200. PubMed ID: 18098144
[TBL] [Abstract][Full Text] [Related]
33. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
[TBL] [Abstract][Full Text] [Related]
35. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
37. T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120.
Masiero S; Del Vecchio C; Gavioli R; Mattiuzzo G; Cusi MG; Micheli L; Gennari F; Siccardi A; Marasco WA; Palù G; Parolin C
Gene Ther; 2005 Feb; 12(4):299-310. PubMed ID: 15496956
[TBL] [Abstract][Full Text] [Related]
38. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
39. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
